Idarubicin-intensified haploidentical HSCT with GvHD prophylaxis of ATG and basiliximab provides comparable results to sibling donors in high-risk acute leukemia

Zhang R,Shi W,Wang Hf,You Y,Zhong Zd,Li Wm,Zhang C,Xuan Lu,Wang Yd,Zheng P,J. Fang,M. Hong,Wu Ql,Xia Lh

Idarubicin-intensified haploidentical HSCT with GvHD prophylaxis of ATG and basiliximab provides comparable results to sibling donors in high-risk acute leukemia

2017

Zhang R
Shi W
Wang Hf
You Y
Zhong Zd
Li Wm
Zhang C
Xuan Lu
Wang Yd
Zheng P
J. Fang
M. Hong
Wu Ql
Xia Lh

Idarubicin-intensified haploidentical HSCT with GvHD prophylaxis of ATG and basiliximab provides comparable results to sibling donors in high-risk acute leukemia

Keywords:

Immunology
Progenitor cell
Idarubicin
Transplantation
Basiliximab
Graft-versus-host disease
Medicine
Stem cell
Acute leukemia
High Risk Acute Leukemia
Hematopoietic stem cell transplantation
Transplantation Conditioning

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations